Location History:
- Stamford, GB (1981 - 2010)
- Slough, GB (2019 - 2023)
Company Filing History:
8 out of 109 
6 out of 138 
2 out of 3 Years Active: 1981-2025
Title: Inventor Michael John Wright: A Leader in Antibody Innovations
Introduction
Michael John Wright, based in Slough, GB, is a prominent inventor known for his significant contributions to the field of biotechnology and therapeutic innovations. With a remarkable total of 14 patents to his name, Wright has made substantial advancements, particularly in the development of antibody molecules that target critical proteins involved in various medical conditions.
Latest Patents
Among his latest innovations, one notable patent involves antibody molecules that specifically bind to CD22, highlighting their potential therapeutic uses. This patent includes a detailed description of the binding domains, aimed at creating pharmaceutical compositions that leverage these antibody molecules in treatment applications.
Another significant patent concerns the crystal structure of the human Gremlin-1 protein, along with its complex formation with an inhibitory antibody. This invention not only analyzes the structure of Gremlin-1 but also opens avenues for screening agents that can modulate its activity. The patent emphasizes the development of antibodies targeting an allosteric inhibitory site on Gremlin-1, presenting new opportunities for medical advancements.
Career Highlights
Throughout his career, Wright has been associated with notable companies such as UCB Biopharma Srl and UCB Biopharma Sprl. His work in these organizations has allowed him to contribute substantially to the biopharmaceutical industry, focusing on innovative therapeutic strategies.
Collaborations
Wright has worked alongside accomplished professionals such as Helene Margaret Finney and Stephen Edward Rapecki. Their collaborations have likely fostered synergistic advancements in the projects they undertook, further enhancing the field of biopharmaceutical research.
Conclusion
Michael John Wright exemplifies the spirit of innovation in the biotechnology sector, with his numerous patents and collaborative efforts paving the way for future advancements in medical treatments. His focus on antibody molecules and protein interactions signifies a lasting impact on the health sciences, making him a noteworthy inventor in today's landscape.